MedPath

Short- and Long-term outcomes of robotic gastrectomy for gastric cancer: multi-institutional retrospective study

Phase 2
Conditions
gastric cancer
Registration Number
JPRN-UMIN000034366
Lead Sponsor
Fujita Health University
Brief Summary

Of the 1,127 patients in the previous study, 326 and 752 patients in the RG and LG groups, respectively, completed the study. In the weighted population, 3yOS was 96.3% and 89.6% in the RG and LG groups, respectively (hazard ratio [HR], 0.34 [0.15, 0.76]; p = 0.009), whereas there was no difference in three-year recurrence-free survival rate (3yRFS) between the two groups (HR, 0.58 [0.32, 1.05]; p = 0.073). Sub-analyses showed that RG improved 3yOS and 3yRFS in patients with pStage IA disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1127
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who met the following criteria were excluded: preoperative use of chemotherapy and presence of mental disorders.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3-year OS
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath